Annals of Nuclear Medicine最新文献

筛选
英文 中文
Prognostic impact of stage reclassification and N2 subclassification in the ninth edition of TNM classification for non-metastatic lung cancer. 第九版TNM分期重分及N2亚分对非转移性肺癌预后的影响
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-03-28 DOI: 10.1007/s12149-026-02198-w
Muhammet Halil Baltacioglu, Demet Nak, Pelin Sahin Oguz, Ogün Bulbul
{"title":"Prognostic impact of stage reclassification and N2 subclassification in the ninth edition of TNM classification for non-metastatic lung cancer.","authors":"Muhammet Halil Baltacioglu, Demet Nak, Pelin Sahin Oguz, Ogün Bulbul","doi":"10.1007/s12149-026-02198-w","DOIUrl":"https://doi.org/10.1007/s12149-026-02198-w","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147571966","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of simulation settings, time-activity curve integration range, and imaging time points on full Monte Carlo-based 177Lu-DOTATATE dosimetry. 模拟设置、时间-活动曲线积分范围和成像时间点对完全基于蒙特卡罗的177Lu-DOTATATE剂量学的影响。
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-03-28 DOI: 10.1007/s12149-026-02197-x
Shu Kimura, Noriaki Miyaji, Kenta Miwa, Tensho Yamao, Masaki Masubuchi, Naochika Akiya, Kaito Wachi, Arata Komatsu, Ryuichi Nishii, Kohei Nakanishi, Yuto Kamitaka, Kosuke Yamashita, Takuya Furuta, Tatsuhiko Sato
{"title":"Impact of simulation settings, time-activity curve integration range, and imaging time points on full Monte Carlo-based <sup>177</sup>Lu-DOTATATE dosimetry.","authors":"Shu Kimura, Noriaki Miyaji, Kenta Miwa, Tensho Yamao, Masaki Masubuchi, Naochika Akiya, Kaito Wachi, Arata Komatsu, Ryuichi Nishii, Kohei Nakanishi, Yuto Kamitaka, Kosuke Yamashita, Takuya Furuta, Tatsuhiko Sato","doi":"10.1007/s12149-026-02197-x","DOIUrl":"https://doi.org/10.1007/s12149-026-02197-x","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147571823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adenosine FDG PET/CT reveals potentially viable myocardium in ischemic cardiomyopathy. 腺苷FDG PET/CT显示缺血性心肌病的潜在存活心肌。
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-03-27 DOI: 10.1007/s12149-026-02196-y
Mutlay Keskin
{"title":"Adenosine FDG PET/CT reveals potentially viable myocardium in ischemic cardiomyopathy.","authors":"Mutlay Keskin","doi":"10.1007/s12149-026-02196-y","DOIUrl":"https://doi.org/10.1007/s12149-026-02196-y","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147525737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-metastatic castration-resistant prostate cancer in the epoch of PSMA-ligand PET/CT: twilight? psma配体PET/CT时代的非转移性去势抵抗性前列腺癌:黄昏?
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-03-26 DOI: 10.1007/s12149-026-02195-z
Pipitsa N Valsamaki, Georgios Tsakaldimis
{"title":"Non-metastatic castration-resistant prostate cancer in the epoch of PSMA-ligand PET/CT: twilight?","authors":"Pipitsa N Valsamaki, Georgios Tsakaldimis","doi":"10.1007/s12149-026-02195-z","DOIUrl":"https://doi.org/10.1007/s12149-026-02195-z","url":null,"abstract":"<p><p>The introduction of prostate-specific membrane antigen-ligand positron emission tomography/computerised tomography (PSMA-ligand PET/CT) into clinical practice has altered the prevalence of non‑metastatic (by conventional imaging) castration-resistant prostate cancer (nmCRPC). We herewith briefly review the biochemical and imaging parameters in nmCRPC and mainly focus on decoding disease localization using PSMA- ligand PET. The effective restaging with more accurate PSMA PET-based disease identification and characterization potentially signifies the entrance of the nmCRPC stage in the twilight zone. Moreover, it seems plausible that the small fraction of the nmCRPC invisible even on PSMA PET may constitute a latent phase of occult growth of the tumor cells. Supposedly, triggering of PSMA overexpression on the PCa cells under androgen deprivation therapy (ADT) through certain anticancer or other therapies such as protein kinase inhibitors (PKIs), dutasteride, or cholesterol-lowering regimes, might further hasten visualisation of micrometastases on PSMA-ligand PET, eventually transforming the nmCRPC stage into a defined, potentially curable target.</p>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147519761","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
SPECT and PET imaging of Alzheimer’s disease revisited: from biomarkers to artificial intelligence-based prediction 阿尔茨海默病的SPECT和PET成像重新审视:从生物标志物到基于人工智能的预测。
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-03-26 DOI: 10.1007/s12149-026-02194-0
Ioannis Tsougos, Varvara Valotassiou, Dimitra Tsivaka, Maria Satra, George Angelidis, John Papatriantafyllou, Emmanouil Panagiotidis, Efthimios Dardiotis, George Hadjigeorgiou, Panagiotis Georgoulias
{"title":"SPECT and PET imaging of Alzheimer’s disease revisited: from biomarkers to artificial intelligence-based prediction","authors":"Ioannis Tsougos,&nbsp;Varvara Valotassiou,&nbsp;Dimitra Tsivaka,&nbsp;Maria Satra,&nbsp;George Angelidis,&nbsp;John Papatriantafyllou,&nbsp;Emmanouil Panagiotidis,&nbsp;Efthimios Dardiotis,&nbsp;George Hadjigeorgiou,&nbsp;Panagiotis Georgoulias","doi":"10.1007/s12149-026-02194-0","DOIUrl":"10.1007/s12149-026-02194-0","url":null,"abstract":"<div>\u0000 \u0000 <p>In Alzheimer’s disease (AD), PET and SPECT enable in-vivo imaging of β-amyloid, tau, cerebral metabolism, and neuroinflammation. However, classical interpretation, including visual reads, ROI summaries, and SUVR thresholds, remains limited by reader variability, dependence on reference regions, and cross-site heterogeneity. Building upon our previous review on SPECT and PET imaging in AD, this article revisits molecular neuroimaging through the lens of artificial intelligence (AI), integrating advances from radiomics and classical machine learning to deep learning that support more quantitative and predictive use of PET/SPECT. Methods are organized by clinical objective, including diagnostic and differential classification, segmentation for region-wise measurement, automated quantification, image enhancement and reconstruction (attenuation correction, denoising, super-resolution, low-dose/short-scan recovery), and prognostic modeling (conversion and cognitive decline). We summarize key data resources, benchmarking, and standardization /harmonization strategies that improve generalization across scanners and tracers. Finally, we outline practical requirements for translation: models should provide well-calibrated probabilities, indicate when predictions are uncertain, offer outputs consistent with AD-relevant biology, report performance across relevant subgroups, and follow transparent reporting standards with clinically usable outputs, supporting earlier detection and more consistent monitoring in AD.</p>\u0000 </div>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":"40 5","pages":"480 - 495"},"PeriodicalIF":2.5,"publicationDate":"2026-03-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s12149-026-02194-0.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147519745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lesion-level quantitative Lu-177 PSMA SPECT/CT SUV metrics are associated with interim treatment response in mCRPC: a PET-correlated study. 一项与pet相关的研究表明,病灶水平定量的lu177 PSMA SPECT/CT SUV指标与mCRPC的中期治疗反应相关。
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-03-18 DOI: 10.1007/s12149-026-02193-1
Berkay Çağdaş, Elif Kardelen Çağdaş, Alptuğ Özer Yüksel, Hüseyin Şan, Nilüfer Yildirim
{"title":"Lesion-level quantitative Lu-177 PSMA SPECT/CT SUV metrics are associated with interim treatment response in mCRPC: a PET-correlated study.","authors":"Berkay Çağdaş, Elif Kardelen Çağdaş, Alptuğ Özer Yüksel, Hüseyin Şan, Nilüfer Yildirim","doi":"10.1007/s12149-026-02193-1","DOIUrl":"https://doi.org/10.1007/s12149-026-02193-1","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147479490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of energy deposition pixel kernel convolution for planar dosimetry in 177Lu therapy. 能量沉积像元核卷积在平面剂量学中的应用。
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-03-16 DOI: 10.1007/s12149-026-02191-3
Phornpailin Pairodsantikul, Mizuki Matsushita, Mei Takahashi, Kyeong Min Kim, Hiroshi Watabe, Monchaya Nivorn, Paramest Wongsa, Miho Shidahara
{"title":"Development of energy deposition pixel kernel convolution for planar dosimetry in <sup>177</sup>Lu therapy.","authors":"Phornpailin Pairodsantikul, Mizuki Matsushita, Mei Takahashi, Kyeong Min Kim, Hiroshi Watabe, Monchaya Nivorn, Paramest Wongsa, Miho Shidahara","doi":"10.1007/s12149-026-02191-3","DOIUrl":"https://doi.org/10.1007/s12149-026-02191-3","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147466782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The diagnostic and therapeutic value of FDG PET/CT for infectious diseases in FUO/IUO patients. FDG PET/CT对FUO/IUO患者感染性疾病的诊断和治疗价值
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-03-16 DOI: 10.1007/s12149-026-02190-4
Peixuan Wu, Keji Hao, Yuan Li, Yue Wang, Yan Gao, Qian Wang
{"title":"The diagnostic and therapeutic value of FDG PET/CT for infectious diseases in FUO/IUO patients.","authors":"Peixuan Wu, Keji Hao, Yuan Li, Yue Wang, Yan Gao, Qian Wang","doi":"10.1007/s12149-026-02190-4","DOIUrl":"https://doi.org/10.1007/s12149-026-02190-4","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-03-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147466803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lymphatic mapping and sentinel lymph node biopsy in urinary bladder cancer: A SPECT/CT-based experience. 膀胱癌的淋巴定位和前哨淋巴结活检:基于SPECT/ ct的经验。
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-03-13 DOI: 10.1007/s12149-026-02181-5
Amin Saber Tanha, Ramin Sadeghi, Hamidreza Ghorbani, Salman Soltani, Atena Aghaee, Leili Zarifmahmoudi, Keyvan Sadri, Hasan Mehrad-Majd, Mohammad Asl Zare
{"title":"Lymphatic mapping and sentinel lymph node biopsy in urinary bladder cancer: A SPECT/CT-based experience.","authors":"Amin Saber Tanha, Ramin Sadeghi, Hamidreza Ghorbani, Salman Soltani, Atena Aghaee, Leili Zarifmahmoudi, Keyvan Sadri, Hasan Mehrad-Majd, Mohammad Asl Zare","doi":"10.1007/s12149-026-02181-5","DOIUrl":"https://doi.org/10.1007/s12149-026-02181-5","url":null,"abstract":"<p><strong>Objective: </strong>Sentinel lymph node (SLN) mapping in bladder cancer has the potential to improve nodal staging while minimizing the morbidity associated with pelvic lymph node dissection (PLND). However, its feasibility, diagnostic accuracy, and influencing factors-including tumor stage, neoadjuvant chemotherapy (NAC), and imaging modality-remain under investigation.</p><p><strong>Materials and methods: </strong>In this prospective study, 35 patients with T1-T4 urothelial carcinoma undergoing radical cystectomy and bilateral PLND were enrolled. Preoperative cystoscopic peritumoral injection of <sup>99m</sup>Tc-phytate was followed by planar lymphoscintigraphy and SPECT/CT. Intraoperative SLN detection utilized a handheld gamma probe. SLN identification was compared with standard PLND findings using patient- and hemipelvis-based analyses to determine detection rates, sensitivity, and false-negative rates.</p><p><strong>Results: </strong>A total of 54 SLNs were identified in 24 patients (37 hemipelves). Patient-based detection rates were 68.6% for intraoperative gamma probe, 51.4% for SPECT/CT, and 45.7% for planar imaging. Hemipelvis-based detection rates were 52.9%, 40.0%, and 34.3%, respectively. Detection rates were highest in T1-T2, NAC-positive patients, with 100% intraoperative localization. Histopathological analysis identified nodal metastases in seven patients; SLNs were identified in four patients, three of whom showed concordant SLN involvement, while one showed no SLN involvement. The patient-based false-negative rate was 25%, while hemipelvis-based analysis showed no false negatives. Aberrant SLNs outside the standard PLND template were identified in 6% of patients, highlighting variable lymphatic drainage.</p><p><strong>Conclusion: </strong>SLN mapping in bladder cancer is technically feasible and identifies atypical drainage patterns, with performance influenced by tumor stage, NAC, and imaging modality. SLN mapping may complement PLND by improving anatomical staging and may ultimately allow more tailored or minimally invasive lymphadenectomy in selected patients.</p>","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":" ","pages":""},"PeriodicalIF":2.5,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147455156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: Subcutaneous/cutaneous uptake in the cancer-affected breast on 18F-FDG PET/CT: association with post-surgical prognosis in breast cancer patients 更正:18F-FDG PET/CT显示患癌乳腺皮下/皮肤摄取:与乳腺癌患者术后预后的关系。
IF 2.5 4区 医学
Annals of Nuclear Medicine Pub Date : 2026-03-13 DOI: 10.1007/s12149-026-02188-y
Yurika Kitano, Kanae K. Miyake, Tomomi W. Nobashi, Takayoshi Ishimori, Ryusuke Nakamoto, Sho Koyasu, Masako Kataoka, Yasuhide Takeuchi, Masakazu Toi, Yuji Nakamoto
{"title":"Correction: Subcutaneous/cutaneous uptake in the cancer-affected breast on 18F-FDG PET/CT: association with post-surgical prognosis in breast cancer patients","authors":"Yurika Kitano,&nbsp;Kanae K. Miyake,&nbsp;Tomomi W. Nobashi,&nbsp;Takayoshi Ishimori,&nbsp;Ryusuke Nakamoto,&nbsp;Sho Koyasu,&nbsp;Masako Kataoka,&nbsp;Yasuhide Takeuchi,&nbsp;Masakazu Toi,&nbsp;Yuji Nakamoto","doi":"10.1007/s12149-026-02188-y","DOIUrl":"10.1007/s12149-026-02188-y","url":null,"abstract":"","PeriodicalId":8007,"journal":{"name":"Annals of Nuclear Medicine","volume":"40 4","pages":"460 - 464"},"PeriodicalIF":2.5,"publicationDate":"2026-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147455107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书